Detalles de la búsqueda
1.
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
Lancet
; 403(10443): 2504-2519, 2024 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38795716
2.
Bimekizumab versus Secukinumab in Plaque Psoriasis.
N Engl J Med
; 385(2): 142-152, 2021 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33891380
3.
Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3â years of treatment in randomized phase III trials.
Br J Dermatol
; 190(4): 477-485, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37950894
4.
Bimekizumab efficacy and safety in patients with moderate-to-severe plaque psoriasis who switched from adalimumab, ustekinumab or secukinumab: results from phase III/IIIb trials.
Br J Dermatol
; 188(3): 330-340, 2023 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36751950
5.
Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial.
Br J Dermatol
; 188(1): 22-31, 2023 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36689515
6.
Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial.
Lancet
; 397(10273): 475-486, 2021 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33549192
7.
Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial.
Lancet
; 397(10273): 487-498, 2021 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33549193
8.
Bimekizumab for patients with moderate to severe plaque psoriasis: 60-week results from BE ABLE 2, a randomized, double-blinded, placebo-controlled, phase 2b extension study.
J Am Acad Dermatol
; 83(5): 1367-1374, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32473974
9.
Sports medicine and school nurses: a growing need for further education and appropriate resources.
J Sch Health
; 76(1): 8-11, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16457679
Resultados
1 -
9
de 9
1
Próxima >
>>